< Back to search
Filter
1

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

for
Neoplasms, Head and Neck
Location: Worcester MA, Farmington CT, New Haven CT, The Bronx NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06256588

Phase3, Recruiting

Feasibility of Prospective Surveillance and Early Physical Therapy for Trismus

for
Head and Neck Cancer, Trismus
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06531083

Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

for
Gastric or Gastroesophageal Junction Adenocarcinoma,
Location: Fairfax VA, Durham NC, Pittsburgh PA, Louisville KY,
Sponsor: Phanes Therapeutics

Sex: All

Age: 18+

Code: NCT05482893

Phase1, Phase2, Recruiting

Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck

for
Head and Neck Cancer
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT04805528

Recruiting

Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations

for
Head and Neck Cancer
Location: New York NY, Kansas City KS
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT06030011

Recruiting

Interested in new pancreatic cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

for
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Durham NC, Charleston SC, St Louis MO, Houston TX
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT05793151

Recruiting

A Motion Exergaming Approach for Symptom Management: HNC

for
Head and Neck Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT04632654

Recruiting

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.

for
Head and Neck Squamous Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06162377

Recruiting

Feasibility Study of CBCT for IGRT in Cancer Patients

for
Head and Neck Cancers, Breast Cancer, Thoracic Cancers,
Location: Columbus OH
Sponsor: Varian, a Siemens Healthineers Company

Sex: All

Age: 18+

Code: NCT06681233

Recruiting

Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

for
Head and Neck Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 19+

Code: NCT05901545

Phase1, Recruiting

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body

for
Head and Neck Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03145077

Recruiting

A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

for
Solid Tumor, Adult, Colorectal Cancer,
Location: Houston TX
Sponsor: Crossignal Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06598007

Phase1, Phase2, Recruiting

Phase II Panitumumab-IRDye800 in Head & Neck Cancer

for
Head and Neck Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT04511078

Phase2, Recruiting

Lead-212 PSV359 Therapy for Patients With Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Miami FL, Pittsburgh PA, Columbus OH, Lexington KY,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06710756

Phase1, Phase2, Recruiting

Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).

for
Head and Neck Squamous Cell Carcinoma
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT05977907

Phase2, Recruiting

Feasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically

for
Dysphagia, Head and Neck Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06192771

Recruiting

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

for
Head and Neck Squamous Cell Carcinoma,
Location: Weston WI, Bremerton WA
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT02734537

Phase2, Recruiting

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

for
Metastatic Pancreatic Adenocarcinoma
Location: Port Huron MI, Detroit MI, Lapeer MI, Clarkston MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT06576115

Phase2, Recruiting

Determining Individualized Cancer Therapy in Pancreatic Cancer

for
Pancreatic Neoplasms
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT05914987

Recruiting

Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program

for
Pancreatic Ductal Adenocarcinoma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT03865875

Recruiting